Phase II trial of weekly docetaxel and capecitabine in advanced renal cell carcinoma.

被引：0
|
作者：
Vaishampayan, UN [1 ]
Heilbrun, LK [1 ]
Eliason, J [1 ]
Pontes, E [1 ]
Forman, J [1 ]
Cher, M [1 ]
机构：
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4672
引用
收藏
页码：424S / 424S
页数：1
相关论文
共 50 条
  • [1] Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma
    Marur, Shanthi
    Eliason, James
    Helibrun, Lance K.
    Dickow, Brenda
    Smith, Daryn W.
    Baranowski, Karen
    Alhasan, Samir
    Vaishampayan, Ulka
    [J]. UROLOGY, 2008, 72 (04) : 898 - 902
  • [2] A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma
    Han, JY
    Lee, DH
    Kim, HY
    Hong, EK
    Yoon, SM
    Chun, JH
    Lee, HG
    Lee, SY
    Shin, EH
    Lee, JS
    [J]. CANCER, 2003, 98 (09) : 1918 - 1924
  • [3] A phase II trial of neoadjuvant chemotherapy with docetaxel/cisplatin/capecitabine in thoracic esophageal squamous cell carcinoma.
    Wu, Xiaobin
    Ling, Jiayu
    Li, Shanshan
    Xiang, Jun
    Deng, Yanhong
    Peng, Junsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] A phase II trial of weekly docetaxel for second-line treatment of urothelial carcinoma.
    Kim, Young Saing
    Choi, Moon Ki
    Hong, Jung Yong
    Maeng, Chi Hoon
    Lee, Soonil
    Hwang, In Gyu
    Lee, Sang-Cheol
    Sun, Jong-Mu
    Park, Se Hoon
    Lee, Jeeyun
    Lim, Ho Yeong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.
    Yamouni, M.
    Beldjilali, Y.
    Benhadji, K. A.
    Khellafi, H.
    Betkaoui, F.
    Kaid, Y.
    Benchlef, L.
    Daim, F. Z.
    Toubal, S.
    Boukerche, A.
    Abdelaoui, A.
    Djellali, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study
    Orditura, M.
    Aurilio, G.
    Galizia, G.
    Carlomagno, C.
    Lieto, E.
    Vecchione, L.
    Martinelli, E.
    De Placido, S.
    Catalano, G.
    Ciardiello, F.
    De Vita, F.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [7] Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
    Xuyuan Li
    Wen Lin
    Hongbiao Wang
    Wenzhao Lin
    Suiling Lin
    Yingcheng Lin
    [J]. Medical Oncology, 2013, 30
  • [8] Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
    Li, Xuyuan
    Lin, Wen
    Wang, Hongbiao
    Lin, Wenzhao
    Lin, Suiling
    Lin, Yingcheng
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [9] A phase II study of preoperative docetaxel, cisplatin, and capecitabine in patients with gastric carcinoma.
    Voon, Pei-Jye
    Soe, Mu-Yar
    Zee, Ying Kiat
    Chuah, Benjamin
    Lim, Robert S. C.
    Shabbir, Asim
    So, Jimmy
    Yong, Wei-Peng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [10] A phase II trial with monoclonal antibody CG250 in advanced renal cell carcinoma.
    Varga, Z
    Hegele, A
    Hofmann, R
    De Mulder, PD
    Kruit, W
    Warnaar, S
    Mala, C
    Ullrich, S
    Huber, C
    Lamers, C
    Beck, J
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 192 - 193
12345